Ischemic Heart Disease during Acute Exacerbations of COPD

Ischemic Heart Disease during Acute Exacerbations of COPD

Patients with chronic obstructive pulmonary disease (COPD) have a higher risk of acute cardiovascular events, and around 30% die from cardiovascular diseases. Recent data suggest an increased risk of myocardial infarction in the following days of a severe exacerbation of COPD. Disruption in the bala...

書誌詳細
主要な著者:	Rosa Malo de Molina, Silvia Aguado, Carlos Arellano, Manuel Valle, Piedad Ussetti
フォーマット:	論文
言語:	English
出版事項:	MDPI AG 2018-09-01
シリーズ:	Medical Sciences
主題:	chronic obstructive pulmonary disease cardiovascular myocardial infarction exacerbation treatment beta-blockers
オンライン･アクセス:	http://www.mdpi.com/2076-3271/6/4/83

類似資料

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)
著者:: Sean Duffy, 等
出版事項: (2017-06-01)

Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality – The STATUETTE Cohort Study
著者:: Damkjær M, 等
出版事項: (2021-08-01)

Heart and Lungs in COPD. Close friends in real life - separate in daily medical practice?
著者:: M. Lusuardi, 等
出版事項: (2016-01-01)

Statin Use and the Risk of Subsequent Hospitalized Exacerbations in COPD Patients with Frequent Exacerbations
著者:: Lin CM, 等
出版事項: (2020-02-01)

Treatment of COPD exacerbations: antibiotics
著者:: R. Wilson
出版事項: (2005-09-01)

Comparison of COPD Assessment Test and Clinical COPD Questionnaire to predict the risk of exacerbation
著者:: Jo YS, 等
出版事項: (2017-12-01)

Blood and sputum eosinophilia in COPD exacerbation
著者:: Laila Ashour Helala, 等
出版事項: (2022-09-01)

Study of Sputum Bacteriology of Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease
著者:: Shaila Jay Shah, 等
出版事項: (2021-04-01)

The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study
著者:: Liao KM, 等
出版事項: (2017-08-01)

Handgrip strength during admission for COPD exacerbation: impact on further exacerbation risk
著者:: Chi-Tai Lee, 等
出版事項: (2021-07-01)

Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)
著者:: Seonaidh Cotton, 等
出版事項: (2022-04-01)

Beta adrenergic blokade in myocardial infarction
著者:: Yusuf, S
出版事項: (1980)

Prevention of exacerbations of COPD with pharmacotherapy
著者:: M. Miravitlles
出版事項: (2010-06-01)

RADIOLOGICAL DIAGNOSIS OF COPD EXACERBATIONS
著者:: N. A. Gorbunov, 等
出版事項: (2014-02-01)

Radiological diagnosis of copd exacerbations
著者:: N. A. Gorbunov, 等
出版事項: (2013-11-01)

Relationship Between Blood Eosinophils and Systemic Corticosteroid Therapy in COPD Exacerbation
著者:: Gong Y, 等
出版事項: (2022-09-01)

Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients
著者:: Jeong SH, 等
出版事項: (2016-08-01)

Factors associated with exacerbation in mild-to-moderate COPD patients
著者:: Kim JK, 等
出版事項: (2016-06-01)

Controlled-release carvedilol in the management of systemic hypertension and myocardial dysfunction
著者:: William H Frishman, 等
出版事項: (2008-12-01)

The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD
著者:: Sun T, 等
出版事項: (2020-08-01)

Modulation of airway inflammation to prevent exacerbations of COPD
著者:: M. Solèr
出版事項: (2005-12-01)

METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER
著者:: B. N. Garifullin, 等
出版事項: (2016-01-01)

THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION
著者:: A. N. Zakirova, 等
出版事項: (2017-12-01)

EFFICACY AND SAFETY OF BETA-ADRENOBLOCKER TREATMENT DURING POSTOPERATIONAL PERIOD AFTER EXTRACARDIAL SURGERY - A PARADIGM SHIFT?
著者:: Yu. V. Shchukin, 等
出版事項: (2014-09-01)

Beta-blockers after myocardial infarction: Are they useful to all patients? And how long should be the beta-blocker therapy?
著者:: Roberto F.E. Pedretti
出版事項: (2018-06-01)

The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD [Corrigendum]
著者:: Sun T, 等
出版事項: (2021-03-01)

Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD
著者:: Lai CC, 等
出版事項: (2018-03-01)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
著者:: Calverley PMA, 等
出版事項: (2019-12-01)

Inflammation and infections in unreported chronic obstructive pulmonary disease exacerbations
著者:: Calderazzo MA, 等
出版事項: (2019-04-01)

Impact of Coexisting Dementia on Inpatient Outcomes for Patients Admitted with a COPD Exacerbation
著者:: Gupta A, 等
出版事項: (2022-03-01)

Incidence of utilization- and symptom-defined COPD exacerbations in hospital- and population-recruited patients
著者:: Erdal M, 等
出版事項: (2016-09-01)

Remote Patient Monitoring for the Detection of COPD Exacerbations
著者:: Cooper CB, 等
出版事項: (2020-08-01)

The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients
著者:: Song Q, 等
出版事項: (2021-05-01)

Deterioration Patterns in Patients Admitted for Severe COPD Exacerbation
著者:: Cristhian Alonso Correa-Gutiérrez, 等
出版事項: (2024-11-01)

Functional respiratory imaging: heterogeneity of acute exacerbations of COPD
著者:: van Geffen WH, 等
出版事項: (2018-05-01)

GOLD severity stratification and risk of hospitalisation for COPD exacerbations
著者:: M. Lusuardi, 等
出版事項: (2016-01-01)

Prognostic Nutritional Index (PNI) as a Potential Prognostic Tool for Exacerbation of COPD in Elderly Patients
著者:: Suzuki E, 等
出版事項: (2023-06-01)

Investigation serum procalcitonin in patients with exacerbation of obstructive pulmonary disease
著者:: Mina Delghandi, 等
出版事項: (2020-12-01)

The prescription retroscope – tools for advocating critical and individualised therapy
著者:: Stephane Cook, 等
出版事項: (2020-10-01)

The bisoprolol efficiency predictors in patients with stable angina after myocardial infarction
著者:: O. V. Zamakhina, 等
出版事項: (2019-04-01)